Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Product Quality Reviews (PQRs) for Creams – V 2.0

Posted on By

Creams: SOP for Product Quality Reviews (PQRs) for Creams – V 2.0

Standard Operating Procedure for Product Quality Reviews (PQRs) for Creams

Department Creams
SOP No. SOP/CRM/200/2025
Supersedes SOP/CRM/200/2022
Page No. Page 1 of 6
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the process for conducting Product Quality Reviews (PQRs) for cream products. PQRs ensure that the manufacturing process consistently produces products of the required quality and that any deviations or trends in product quality are identified and addressed in a timely manner.

2. Scope

This SOP applies to the process of conducting PQRs for all cream products manufactured in the Creams department. It covers the evaluation of product quality based on manufacturing, testing, and customer feedback data.

3. Responsibilities

  • QA Manager: Responsible for overseeing the PQR process, ensuring that reviews are conducted on time, and ensuring the results are properly documented.
  • Production Team: Responsible for providing all necessary data related to the manufacturing process, including batch records, test results, and any deviations or non-conformities encountered during production.
  • Regulatory Affairs Team: Responsible for ensuring that the PQR process aligns with regulatory requirements and that any regulatory concerns are addressed during the review.
  • Document
Control Team: Responsible for maintaining all PQR-related documentation and ensuring that the records are accessible for audits and inspections.

4. Accountability

The QA Manager is accountable for ensuring that the PQR process is conducted in accordance with this SOP and that appropriate corrective actions are implemented based on the findings.

5. Procedure

5.1 Scheduling of PQRs

  1. PQRs will be conducted at least once annually for each cream product. The schedule for conducting PQRs will be planned and documented by the QA Manager.
  2. The PQR process should be initiated at least one month prior to the review date to ensure all necessary data is gathered and reviewed.

5.2 Data Collection for PQR

  1. The following data will be collected and reviewed during the PQR:
    • Batch records for each production run, including raw material usage, equipment settings, and environmental conditions.
    • Test results from in-process controls, quality control testing, and final product testing.
    • Results from stability studies, if applicable.
    • Any deviations or non-conformities encountered during production, along with corrective and preventive actions (CAPA) implemented.
    • Customer feedback, including complaints and returns related to product quality.
    • Trend analysis data for key quality attributes such as viscosity, pH, microbial content, and packaging integrity.
  2. The Document Control Team will ensure that all relevant documents are collected and made available for the PQR review.

5.3 Review and Analysis of Data

  1. The QA Manager, in collaboration with the Production Team, will review all collected data to identify any trends, deviations, or potential quality issues.
  2. Trends in quality data will be analyzed to determine if there are any recurring issues or if improvements can be made to the manufacturing process.
  3. Any deviations or non-conformities will be thoroughly investigated, and the effectiveness of corrective actions will be evaluated.
  4. If necessary, the team will consult with the Regulatory Affairs Team to ensure compliance with applicable regulations and guidelines.

5.4 Reporting of PQR Results

  1. After reviewing and analyzing the data, the QA Manager will compile a PQR report that includes the following:
    • A summary of the data reviewed, including batch records, testing results, and stability data.
    • An evaluation of the effectiveness of previous corrective actions.
    • Identification of trends or recurring issues, along with recommendations for corrective actions or process improvements.
    • Customer feedback summary, including any actions taken in response to complaints or returns.
  2. The PQR report will be reviewed by the QA Manager and, if necessary, the Regulatory Affairs Team for regulatory compliance.
  3. The final PQR report will be distributed to relevant departments, including Production, Regulatory Affairs, and Document Control.

5.5 Corrective and Preventive Actions (CAPA)

  1. If the PQR identifies any quality issues or trends that require corrective or preventive actions, the QA Manager will initiate a CAPA process.
  2. The CAPA process will include:
    • Identification of the root cause of the quality issue
    • Implementation of corrective actions to address the issue
    • Preventive actions to avoid recurrence of the issue
    • Monitoring and verification of the effectiveness of the actions taken
  3. The CAPA process will be documented in the CAPA Report (Annexure-1) and reviewed by the QA Manager before implementation.

5.6 Documentation and Record-Keeping

  1. All PQR-related documents, including the PQR report, CAPA reports, and supporting data, will be maintained in accordance with GMP guidelines.
  2. Records of the PQR and related actions will be stored securely and retained for a minimum of five years or as required by regulatory guidelines.
  3. The Document Control Team will ensure that PQR records are easily accessible for audits and regulatory inspections.

5.7 Follow-Up and Monitoring

  1. The QA Manager will ensure that any actions identified in the PQR are implemented and monitored for effectiveness.
  2. Follow-up reviews will be conducted as necessary to ensure that corrective and preventive actions are effective and that the identified trends do not reoccur.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QA: Quality Assurance
  • QC: Quality Control
  • SOP: Standard Operating Procedure
  • PQR: Product Quality Review
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Annexure-1: CAPA Report Template
  2. Annexure-2: Product Quality Review Report Template
  3. Annexure-3: Corrective Action Monitoring Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Quality Systems and Control

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: CAPA Report Template

Issue Corrective Action Preventive Action Responsible Person Completion Date
Viscosity variation Re-calibration of mixing equipment Quarterly equipment checks Production Manager 21/02/2026

Annexure-2: Product Quality Review Report Template

Product Year Batch Records Reviewed Test Results Reviewed Corrective Actions
Cream A 2025 5 Batches Passed all test criteria None

Annexure-3: Corrective Action Monitoring Log

Action Responsible Person Status Completion Date
Re-calibration of viscosity measurement John Doe Completed 21/02/2026

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Documentation Review and Approval in QA - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Analytical Method Development: SOP for TOC Method Development for Cleaning Validation – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Investigations of Complaints Related to Injectable Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version